Effects of Negative Affect in Individuals With Binge Eating Episodes
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Jan 4, 2018
Trial Information
Current as of July 21, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how feelings of distress and negative emotions are linked to binge-eating behaviors in people with eating disorders like Binge Eating Disorder (BED) and Bulimia Nervosa (BN). Researchers want to understand how these feelings may affect the brain's reward system and decision-making processes when it comes to food. By looking at these connections, the study aims to find better treatment options that could help people manage their eating habits and emotional responses.
To participate in the trial, individuals aged 18 to 55 who have either BED or BN, as well as healthy controls and those who are obese, may be eligible. Key criteria include having a specific diagnosis of an eating disorder, maintaining a stable body weight, and not having a history of certain mental health issues or major medical illnesses. Participants will engage in assessments that explore their eating behaviors and emotional states, helping researchers gather valuable information to improve understanding and treatment of binge-eating disorders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy Controls
- • Age 18-55 years old
- • Healthy body weight between 90 and 110 % average body weight since puberty.
- • Regular monthly menstrual cycle (if applicable)
- • Edinburgh Handedness Inventory Revised (EHI-R) LQ\* score \> +200
- • Obese
- • Age 18-55 years old
- • Current body mass index (BMI) \> 30 kg/m2.
- • Stable food intake regimen in previous 4 weeks.
- • Edinburgh Handedness Inventory Revised (EHI-R) LQ\* score \> +200
- • Obese for at least one year
- • Binge Eating Disorder
- • Age 18-55 years old
- • Edinburgh Handedness Inventory Revised (EHI-R) LQ\* score \> +200
- • DSM 5 diagnosis of Binge Eating Disorder A. Recurrent episodes of binge eating B. Binge eating episodes are associated with three (or more) of the following
- • 1. Eating much more rapidly than normal.
- • 2. Eating until feeling uncomfortably full.
- • 3. Eating large amounts of food when not feeling physically hungry.
- • 4. Eating alone because of embarrassment.
- • 5. Feeling disgusted with oneself, depressed, or very guilty after overeating. C. Marked distress regarding binge eating is present. D. At least once a week for 3 months. E. The binge eating is not associated with the recurrent use of inappropriate compensatory behavior.
- • Bulimia Nervosa
- • Age 18-55 years old
- • Edinburgh Handedness Inventory Revised (EHI-R) LQ\* score \> +200
- • DSM 5 diagnosis of Bulimia Nervosa A. Recurrent episodes of binge eating Eating, in a discrete period of time, an amount of food that is definitely larger than most people would eat during a similar period of time and under similar circumstances.
- • A sense of lack of control over eating during the episode. B. Recurrent inappropriate compensatory behavior in order to prevent weight gain, such as self-induced vomiting; misuse of laxatives, diuretics, or other medications; fasting; or excessive exercise.
- • C. At least once a week for 3 months. D. Self-evaluation is unduly influenced by body shape and weight.
- Exclusion Criteria:
- • Healthy Controls
- • Current pregnancy or breast feeding within last 3 months
- • First degree relative with current or past eating disorder
- • Current Medications other than BCP or IUD
- • Past or present Axis I psychiatric disorder including substance or alcohol use disorder as determined through SCID-5 clinical interview
- • First degree relative with an eating disorder
- • Major Medical illness
- • Recent history of suspected substance abuse or a lifetime history of psychostimulant abuse and/or dependence
- • Metal implants or braces
- • Obese
- • Current pregnancy or breast feeding within last 3 months
- • First degree relative with current or past eating disorder
- • Current or previous eating disorder diagnosis
- • Current Medications other than BCP or IUD
- • Past or present Axis I psychiatric disorder including substance or alcohol use disorder as determined through SCID-5 clinical interview
- • Major Medical illness
- • Recent history of suspected substance abuse or a lifetime history of psychostimulant abuse and/or dependence
- • Metal implants or braces
- • Binge Eating Disorder
- • Pregnancy or breast feeding within last 3 months
- • Lifetime history of bipolar disorder or psychosis
- • Use of a psychostimulant within the prior 6 months
- • Recent history of substance abuse or dependence (except for alcohol and cannabis use)
- • Major Medical illness
- • Metal implants or braces
- • Bulimia Nervosa
- • Pregnancy or breast feeding within last 3 months
- • Lifetime history of bipolar disorder or psychosis
- • Use of a psychostimulant within the prior 6 months
- • Recent history of substance abuse or dependence (except for alcohol and cannabis use)
- • Major Medical illness
- • Metal implants or braces
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Guido KW Frank, MD
Principal Investigator
University of California, San Diego
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials